3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
2
Social Stigma
1
Prostatic Neoplasms
1
Noonan Syndrome
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Legius syndrome
1
Hematologic Neoplasms
1
Genetic Diseases, Inborn
1
Generalized Anxiety Disorder
1
Disease
1
Costello Syndrome
1
Cardiofaciocutaneous syndrome
1
Breast Neoplasms
1
Anxiety Disorders
1
Interventions
Blood Specimen Collection
5
pembrolizumab
2
fluciclovine F-18
2
Surveys and Questionnaires
2
Preoperative Exercise
2
Magnetic Resonance Imaging
2
Exercise
2
Cryosurgery
2
Bevacizumab
2
tislelizumab
1
neratinib
1
imetelstat
1
daratumumab
1
atezolizumab
1
abiraterone
1
Waiting Lists
1
Videotape Recording
1
Urine Specimen Collection
1
Transcutaneous Electric Nerve Stimulation
1
Tomography, X-Ray Computed
1
Thoracic Surgical Procedures
1
TIC10 compound
1
Sulfonylurea Compounds
1
Standard of Care
1
Specimen Handling
1
Sodium-Glucose Transporter 2 Inhibitors
1
Serologic Tests
1
Sequence Analysis, RNA
1
S-Adenosylmethionine
1
Referral and Consultation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Waiting Lists
×
1 year
×
Clear all
NCT07620717
2026-06-02
PROCAN-B+
University of Sunderland
Phase NA
Not yet recruiting
300 enrolled